Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Tenaya Therapeutics, Inc. (TNYA) had Free Cash Flow per Share of $-0.21 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-26.86M |
|
-- |
|
-- |
|
$27.54M |
|
$-27.54M |
|
$0.67M |
|
$-26.86M |
|
$-26.86M |
|
$-26.86M |
|
$-26.86M |
|
$-26.86M |
|
$-26.86M |
|
$-27.54M |
|
$-24.85M |
|
109.87M |
|
109.87M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$94.48M |
|
$33.36M |
|
$49.47M |
|
$143.95M |
|
$14.15M |
|
-- |
|
$10.40M |
|
$24.56M |
|
$119.40M |
|
$119.40M |
|
$119.40M |
|
162.66M |
|
| Cash Flow Statement Financials | |
$-23.11M |
|
$22.30M |
|
$50.26M |
|
$4.74M |
|
$54.19M |
|
$49.45M |
|
$3.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.50% |
|
-22.50% |
|
-18.66% |
|
-22.50% |
|
$0.73 |
|
|
Free Cash Flow per Share |
$-0.21 |
$-0.21 |
|